Prognosis of Long‐Term Continuous Renal Replacement Therapy and the Impact of Combined Continuous Intravenous Sodium Infusion Therapy

Akinori Yamaguchi, Atsuyoshi Mita, Kosuke Sonoda, Makoto Harada, Koji Hashimoto, Hiroshi Imamura, Yuji Kamijo · 2026

Read Prognosis of Long‐Term Continuous Renal Replacement Therapy and the Impact of Combined Continuous Intravenous Sodium Infusion Therapy by Akinori Yamaguchi, Atsuyoshi Mita, Kosuke Sonoda, Makoto Harada, Koji Hashimoto, Hiroshi Imamura, Yuji Kamijo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13326960.txt.

Description

Akinori Yamaguchi and team tested if a steady sodium drip added to long-term renal replacement therapy lifts results. Their 2026 re-use of past data took in 46 people with sudden kidney harm needing care for at least seven days. Of these, 24 got plain support and 22 got support plus the steady sodium drip.

People needing such long care tend to fare poorly. Steady blood flow is a key hurdle. The drip group held blood flow steadier, passed more urine, and kept a better fluid balance. Staying alive at 90 days with no need for kidney care hit 42.9% with the drip, against 12.5% with plain care in this group. Staying alive to ICU discharge hit 68.2% against 29.2%. Rates of stopping kidney care were far higher. The team holds that the sodium drip may shore up blood flow and lift stopping and staying-alive rates in this high-risk group.

Catalog record

CREATORAkinori Yamaguchi, Atsuyoshi Mita, Kosuke Sonoda, Makoto Harada, Koji Hashimoto, Hiroshi Imamura, Yuji Kamijo
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE43 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13326960

Browse the full library · About the Tower of Babel